GB1227978A - - Google Patents

Info

Publication number
GB1227978A
GB1227978A GB1227978DA GB1227978A GB 1227978 A GB1227978 A GB 1227978A GB 1227978D A GB1227978D A GB 1227978DA GB 1227978 A GB1227978 A GB 1227978A
Authority
GB
United Kingdom
Prior art keywords
group
methyl
general formula
reaction
phenoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1227978A publication Critical patent/GB1227978A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1227978D 1968-09-13 1968-09-13 Expired GB1227978A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4362868 1968-09-13

Publications (1)

Publication Number Publication Date
GB1227978A true GB1227978A (ja) 1971-04-15

Family

ID=10429626

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1227978D Expired GB1227978A (ja) 1968-09-13 1968-09-13

Country Status (5)

Country Link
BE (1) BE738831A (ja)
DE (1) DE1946638A1 (ja)
FR (1) FR2018062B1 (ja)
GB (1) GB1227978A (ja)
NL (1) NL6913673A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618617A (en) * 1982-03-03 1986-10-21 Sumitomo Chemical Company, Limited Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562186A (en) * 1985-01-22 1985-12-31 Hoechst-Roussel Pharmaceuticals Inc. (1,2,4-Oxadiazol-3-yl)arylmethanones, compositions and pharmaceutical use
EP1047425A4 (en) * 1997-12-17 2009-04-22 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618617A (en) * 1982-03-03 1986-10-21 Sumitomo Chemical Company, Limited Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof

Also Published As

Publication number Publication date
FR2018062B1 (ja) 1974-01-11
NL6913673A (ja) 1970-03-17
BE738831A (ja) 1970-03-12
DE1946638A1 (de) 1970-09-03
FR2018062A1 (ja) 1970-05-29

Similar Documents

Publication Publication Date Title
GB1140748A (en) New carboxylic acid derivatives
GB1505296A (en) 8-thiomethylergolines
ES467890A1 (es) Procedimiento para preparar acido di-n-propilacetico.
GB1227978A (ja)
GB1382513A (en) 1-pyridylalkyl-indole derivatives
GB1164234A (en) Process for the production of Phthalocyanines and Phthalocyanine Derivatives
US3669987A (en) Salts of indole derivatives and a process for preparing the same
GB1432649A (ja)
GB1251696A (ja)
IE41533L (en) Thiomethyl ergolene derivatives
GB1365173A (en) Cyclopentane derivatives
IE792508L (en) Piperidylindoles
ES381579A1 (es) Procedimiento para la preparacion de nuevos acidos ariloxi y ariltio-aceticos.
ES478643A1 (es) Procedimiento de preparacion de nuevos derivados de la n-fe-nilalanina.
GB1139940A (en) Oxazole derivatives
KR890009879A (ko) 5- 아미노-1- 페닐-4-니트로피라졸의 제조방법
GB1481161A (en) 5-(substituted-benzoyloxy)pyrazoles and a process for their conversion to 4-benzoyl-pyrazole derivatives
ES426951A1 (es) Procedimiento para la preparacion de nuevos esteres de aci-dos carboxilicos de 3-(4-bifenilil)-alcanoles.
GB1226981A (ja)
GB1088295A (en) Derivatives of alkanoic acids and methods for their preparation
GB1220599A (en) New furazan derivatives, processes for their production and compositions containing them
GB1099209A (en) 5-sulfamoylanthranilic acid derivatives
ES442069A1 (es) Procedimiento para la preparacion de nuevos derivados de bi-fenilo.
SE7705257L (sv) Sett for framstellning av acetonitrilderivat
ES350186A1 (es) Procedimiento para la preparacion de derivados de furazan.

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees